Correction to: Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry (Journal of Neurology, (2019), 266, 11, (2672-2677), 10.1007/s00415-019-09464-0)

Michael Guger; Christian Enzinger; Fritz Leutmezer; Jörg Kraus; Stefan Kalcher; Erich Kvas; Thomas Berger

ArticleOPEN ACCESS

Correction to: Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry (Journal of Neurology, (2019), 266, 11, (2672-2677), 10.1007/s00415-019-09464-0)

Journal of Neurology

DOI: 10.1007/s00415-019-09535-2

1Citations

5Readers

Abstract

The original version of this article unfortunately contained a mistake. First and last names of the authors were interchanged. The correct author names are given below. Michael Guger · Christian Enzinger · Fritz Leutmezer ·Jörg Kraus · Stefan Kalcher · Erich Kvas · Thomas Berger The original article has been corrected.

Cite

CITATION STYLE

APA

Guger, M., Enzinger, C., Leutmezer, F., Kraus, J., Kalcher, S., Kvas, E., & Berger, T. (2019, November 1). Correction to: Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry (Journal of Neurology, (2019), 266, 11, (2672-2677), 10.1007/s00415-019-09464-0). Journal of Neurology. Dr. Dietrich Steinkopff Verlag GmbH and Co. KG. https://doi.org/10.1007/s00415-019-09535-2

Correction to: Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry (Journal of Neurology, (2019), 266, 11, (2672-2677), 10.1007/s00415-019-09464-0)

Abstract

Cite

Register to see more suggestions